Functional consequences of polymorphism of xenobiotic metabolising enzymes
- 1 December 1998
- journal article
- review article
- Published by Elsevier in Toxicology Letters
- Vol. 102-103, 155-160
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Increased skin tumorigenesis in mice lacking pi class glutathione S -transferasesProceedings of the National Academy of Sciences, 1998
- 10-hydroxylation of nortriptyline in white persons with 0, 1, 2, 3, and 13 functional CYP2D6 genes*Clinical Pharmacology & Therapeutics, 1998
- A Combination of Mutations in the CYP2D6*17(CYP2D6Z) Allele Causes Alterations in Enzyme FunctionMolecular Pharmacology, 1997
- Characterization of a Human GlutathioneS-Transferase μ Cluster Containing a DuplicatedGSTM1 Gene that Causes Ultrarapid Enzyme ActivityMolecular Pharmacology, 1997
- Frequent occurrence of CYP2D6 gene duplication in Saudi ArabiansPharmacogenetics, 1997
- A novel mutant variant of the CYP2D6 gene (CYP2D617) common in a black African population: association with diminished debrisoquine hydroxylase activityBritish Journal of Clinical Pharmacology, 1996
- Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white population*Clinical Pharmacology & Therapeutics, 1995
- Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine.Proceedings of the National Academy of Sciences, 1993
- Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquineThe Lancet, 1993
- Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplificationThe Lancet, 1990